Related references
Note: Only part of the references are listed.CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice
Claudine Tardy et al.
ATHEROSCLEROSIS (2014)
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart et al.
CARDIOVASCULAR DIABETOLOGY (2014)
ATP-Binding Cassette Transporters, Atherosclerosis, and Inflammation
Marit Westerterp et al.
CIRCULATION RESEARCH (2014)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2014)
Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism Cardioprotective functions of HDLs
Kerry-Anne Rye et al.
JOURNAL OF LIPID RESEARCH (2014)
Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia
Diederik F. van Wijk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux
Svetlana Diditchenko et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans
Michael H. Davidson et al.
ATHEROSCLEROSIS (2013)
ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden
Andrea E. Bochem et al.
EUROPEAN HEART JOURNAL (2013)
In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1
Adriaan G. Holleboom et al.
JOURNAL OF LIPID RESEARCH (2013)
High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism Novel Hypotheses and Review of Literature
Mohamad Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
Christiane L. Haase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach
Christiane L. Haase et al.
PLOS GENETICS (2012)
Reversal of Hyperlipidemia With a Genetic Switch Favorably Affects the Content and Inflammatory State of Macrophages in Atherosclerotic Plaques
Jonathan E. Feig et al.
CIRCULATION (2011)
CETP expression reverses the reconstituted HDL-induced increase in VLDL
Yanan Wang et al.
JOURNAL OF LIPID RESEARCH (2011)
Cholesterol Acyltransferase Gene Mutations Have Accelerated Atherogenesis as Assessed by Carotid 3.0-T Magnetic Resonance Imaging Carriers of Lecithin
Raphael Duivenvoorden et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
Zahi A. Fayad et al.
LANCET (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
Margarita de la Llera-Moya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
Ron Waksman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
In Vivo Quantification of Carotid Artery Wall Dimensions 3.0-Tesla MRI Versus B-Mode Ultrasound Imaging
R. Duivenvoorden et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
Ruth Frikke-Schmidt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
18Fluorodeoxyglucose positron emission tomography Imaging of atherosclerotic plaque inflammation is highly reproducible - Implications for atherosclerosis therapy trials
James H. F. Rudd et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Xun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients
Ahmed Tawakol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits
SJ Nicholls et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: Relevance of enzymatic and physicochemical properties
A Kontush et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo
YZ Zhang et al.
CIRCULATION (2003)
High-dose recombinant apolipoprotein A-IMilano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice -: Potential implications for acute plaque stabilization
PK Shah et al.
CIRCULATION (2001)
Lecithin cholesterol acyltransferase
A Jonas
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
